Cargando…

Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma

Tertiary lymphoid structures (TLSs) hold the potential role in the prediction of immunotherapy response in several clinical trials. TLSs in head neck squamous cell carcinoma (HNSCC) have been investigated through IHC analysis, whereas there is no TLS gene signature to evaluate the level of TLS neoge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhonglong, Meng, Xiaoyan, Tang, Xiao, Zou, Weili, He, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198854/ https://www.ncbi.nlm.nih.gov/pubmed/36481914 http://dx.doi.org/10.1007/s00262-022-03310-5

Ejemplares similares

Plac1 Remodels the Tumor Immune Evasion Microenvironment and Predicts Therapeutic Response in Head and Neck Squamous Cell Carcinoma
por: Meng, Xiaoyan, et al.
Publicado: (2022)

Lipid metabolism marker CD36 is associated with (18)FDG-PET/CT false negative lymph nodes in head and neck squamous cell carcinoma
por: Meng, Xiaoyan, et al.
Publicado: (2023)

Tertiary Intratumor Lymphoid Tissue in Colo-Rectal Cancer
por: Bergomas, Francesca, et al.
Publicado: (2011)

B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma
por: Ruffin, Ayana T., et al.
Publicado: (2021)

Intratumoral pan-ErbB targeted CAR-T for head and neck squamous cell carcinoma: interim analysis of the T4 immunotherapy study
por: Papa, Sophie, et al.
Publicado: (2023)

Tertiary lymphoid structures in head and neck squamous cell carcinoma improve prognosis by recruiting CD8 (+) T cells
por: Wang, Mengyao, et al.
Publicado: (2023)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Immunotherapy in Head and Neck Squamous Cell Cancer
por: Denaro, Nerina, et al.
Publicado: (2018)

Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma
por: Rasmussen, Jacob H., et al.
Publicado: (2019)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer
por: Hiraoka, N, et al.
Publicado: (2015)

APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures
por: Morcrette, Guillaume, et al.
Publicado: (2019)

Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance
por: Zou, Xuan, et al.
Publicado: (2023)

The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches
por: Economopoulou, Panagiota, et al.
Publicado: (2017)

Constrast-enhanced computed tomography radiomics predicts CD27 expression and clinical prognosis in head and neck squamous cell carcinoma
por: Wang, Fang, et al.
Publicado: (2022)

Tertiary Lymphoid Structures as Mediators of Immunotherapy Response
por: Vaghjiani, Raj G., et al.
Publicado: (2022)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Hsieh, Ronan W., et al.
Publicado: (2021)

Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer
por: Zhang, Yueming, et al.
Publicado: (2020)

Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer
por: He, Miao, et al.
Publicado: (2023)

Spatial Profiles of Intratumoral PD-1(+) Helper T Cells Predict Prognosis in Head and Neck Squamous Cell Carcinoma
por: Yoshimura, Kanako, et al.
Publicado: (2021)

Imaging Features of Intratumoral Injection of NBTXR3 for Head and Neck Squamous Cell Carcinoma Lymph Node Metastases
por: Ginat, Daniel Thomas, et al.
Publicado: (2022)

The Intratumor Bacterial and Fungal Microbiome Is Characterized by HPV, Smoking, and Alcohol Consumption in Head and Neck Squamous Cell Carcinoma
por: Chakladar, Jaideep, et al.
Publicado: (2022)

Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy
por: Zou, Xinlei, et al.
Publicado: (2023)

Potential Role of the Intratumoral Microbiota in Prognosis of Head and Neck Cancer
por: Hamada, Masakazu, et al.
Publicado: (2023)

Pediatric Lymphoid and Histiocytic Lesions in the Head and Neck
por: Auerbach, A., et al.
Publicado: (2021)

Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma
por: Qi, Xinmeng, et al.
Publicado: (2017)

Immunotherapies and Future Combination Strategies for Head and Neck Squamous Cell Carcinoma
por: Cristina, Valerie, et al.
Publicado: (2019)

Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
por: Mei, Zi, et al.
Publicado: (2020)

Immunotherapy in head and neck squamous cell carcinoma: a narrative review
por: Sharon, Shay, et al.
Publicado: (2022)

Diagnostic Predictors of Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
por: Meliante, Piero Giuseppe, et al.
Publicado: (2023)

A Metabolic Gene Signature to Predict Overall Survival in Head and Neck Squamous Cell Carcinoma
por: Wu, Zeng-Hong, et al.
Publicado: (2020)

Systematic Profiling of Immune Risk Model to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
por: Liu, Xingyu, et al.
Publicado: (2020)

Tertiary lymphoid structure signatures are associated with survival and immunotherapy response in muscle-invasive bladder cancer
por: Zhou, Lin, et al.
Publicado: (2021)

Resensitization to Nivolumab after Intratumoral Chemotherapy in Recurrent Head and Neck Squamous Cell Cancer: A Report of 2 Cases
por: Houessinon, Aline, et al.
Publicado: (2020)

Identification and validation of a prognostic signature and combination drug therapy for immunotherapy of head and neck squamous cell carcinoma
por: Qiang, Weijie, et al.
Publicado: (2021)

Impaired intratumoral natural killer cell function in head and neck carcinoma
por: Mele, Dalila, et al.
Publicado: (2022)

Immunotherapy Breakthroughs in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Borel, Christian, et al.
Publicado: (2020)

Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era
por: Saba, Nabil F., et al.
Publicado: (2022)

Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma
por: Yu, Chenhang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ernjnjeg872s5p4rci23dfijsa